As a boutique CRO, we provide focused biostatistics support across clinical development with emphasis on quality, traceability, and regulatory alignment.
The Journey Begins...
In 2013, Dr. Nirali Mehta took a bold step to create PHARMA-STATS, aiming to transform pharmaceutical statistics. Despite juggling the responsibilities of a new venture, a young child, and family commitments, she embarked on her entrepreneurial journey with determination. Remarkably, she even pursued her PhD after starting PHARMA-STATS, proving her relentless dedication to mastering her craft and making an impact.
Today, PHARMA-STATS stands tall, having trained over 400 qualified biostatisticians and 1,000+ researchers, becoming an industry benchmark. We are proud to be the one and only institute in India offering niche biostatistics training through rigorous offline and online courses, strengthening India’s role in building a powerful team of biostatisticians for drug development research.
Her expertise has made her a trusted consultant in Europe and the US. Her belief is simple yet profound: “Nothing in biostatistics is difficult if you truly understand the drug development process.”
our journey
Foundation (2013)
In 2013, PHARMA-STATS was born with a mission to revolutionize pharmaceutical statistics services and training. What started with a vision to redefine how data could drive drug development quickly became a movement starting from pharmaceutical formulation development to clinical trial submission. We launched our journey with a small but determined team, serving an initial clientele of 6. This was the spark that ignited our path toward changing the game in biostatistics services and training.
Expansion (2013-2015)
The next phase? Expansion. We took our biostatistical consulting to the next level, collaborating with R&D and CRO sectors. Our client base grew 150%, reaching 15 companies in a short span. Alongside, we hosted 9 workshops, where we didn’t just share knowledge—we redefined it. This period marked the beginning of something big.
Scaling Up (2015-2018)
From 2015 to 2018, we didn’t just grow—we scaled. PHARMA-STATS expanded into R&D, CRO, and IT sectors, establishing ourselves as the go-to experts in the field. Our clientele skyrocketed to over 50 companies, covering 10 therapeutic areas. We built a powerhouse team of 5 biostatisticians and programmers, and with over 25 workshops conducted, we solidified our reputation as the leaders who get things done.
Consulting & Services (2018-2022)
This was our phase of acceleration. We took our expertise global, consulting for 90+ clients across 5 countries, covering 14 therapeutic areas. Our elite team of 6 biostatisticians and programmers became the go-to experts for regulatory consulting and advisory roles. We didn’t just train talent—we created a talent pipeline, training and placing approximately 350 postgraduate statisticians from 2013 to 2022. With over 30 workshops, we weren’t just part of the industry; we were leading it in biostatistics training and end-to-end services.
Amazing Client Base (2023-2025)
Today, PHARMA-STATS working experience with over 110+ clients across 5 countries. We’re not just another company—we’re the trusted partner with expertise in 18 therapeutic areas. We’ve integrated cutting-edge automation techniques in data analysis, setting a new standard for the industry. This phase truly reflects our dedication to delivering top-notch services and being at the forefront of innovation in biostatistics.
Launch of New Services (2026 and Beyond)
The future is here. We’ve launched predictive analytics and real-world evidence (RWE) services, bringing next-gen data science to life. Our tailor-made statistical tools are empowering pharma and biotech companies across the US and EU, helping them accelerate the drug development process. We’ve contributed to successful regulatory submissions and have been recognized with industry awards. But this is just the beginning. We’re not just shaping the future of biostatistics—we’re creating it.
Countries
Germany
United States
United Kingdom
Malaysia
China
India
Canada
United Arab Emirates